Identification of predictive markers of response to the MEK1/2 inhibitor selumetinib (AZD6244) in K-ras-mutated colorectal cancer.
Tentler
John J
JJ
Division of Medical Oncology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado 80045, USA. john.tentler@ucdenver.edu
Nallapareddy
Sujatha
S
Tan
Aik Choon
AC
Spreafico
Anna
A
Pitts
Todd M
TM
Morelli
M Pia
MP
Selby
Heather M
HM
Kachaeva
Maria I
MI
Flanigan
Sara A
SA
Kulikowski
Gillian N
GN
Leong
Stephen
S
Arcaroli
John J
JJ
Messersmith
Wells A
WA
Eckhardt
S Gail
SG